Low Pulmonary Artery Pulsatility Index May Identify High Risk for Cardiovascular Disease
Researchers examined the relationship between pulmonary artery pulsatility index and multiple adverse outcomes in patients at risk for cardiovascular disease.
Pulmonary Vascular Disorders
Hemodynamic Variables in Pulmonary Hypertension Due to Left Heart Disease
A prospective registry study evaluated the prognostic value of multiple pulmonary hemodynamic variables for risk prediction in PH-LHD.
Elevated Pulmonary Artery Systolic Pressure Among Patients With Heart Failure Indicates Poorer Clinical Outcomes
The purpose of this study was to determine whether baseline pulmonary hypertension influences the outcome of transcatheter mitral valve repair (TMVr) in patients presenting with HF with SMR.
No Causal Association Between Red Cell Distribution Width and PAH
No causal association between elevated red cell distribution width and pulmonary arterial hypertension was established.
E-Cigarettes Associated With Vascular Dysfunction and Adverse Lipid Profile
Similar to results among people who smoked traditional cigarettes, e-cigarette smoking negatively effects heart disease risk factors, namely, cholesterol, triglycerides and glucose levels, and decreases blood flow in the heart.
Thrombolysis During CPR Increases Survival in PE-Related Cardiac Arrest
Patients who received thrombolysis during cardiopulmonary resuscitation for out-of-hospital cardiac arrest with confirmed pulmonary embolism had significantly higher 30-day survival rates vs patients who did not receive thrombolysis.
Sildenafil Oral Suspension Now Available to Treat Pulmonary Arterial Hypertension
The FDA gave approval to market Sildenafil for Oral Suspension, 10mg/mL, a generic of Pfizer’s Revatio for oral suspension which is currently listed on the FDA’s drug shortages list.
Dry Powder Formulation of Treprostinil Appears Safe, Tolerable in PAH
Use of the dry powder formulation of treprostinil, known as LIQ861, has demonstrated safety and tolerability in patients with pulmonary arterial hypertension beyond 2 weeks.
Pulmonary Hypertension Survival Predicted by Cardiopulmonary Reserve Index
The cardiopulmonary reserve index is an effective predictor of prognosis in patients with pulmonary hypertension, particularly when pulmonary hypertension is caused by left heart disease.
Drug-Induced Pulmonary Arterial Hypertension: A More Complicated Prognosis
The prognosis for patients with idiopathic pulmonary arterial hypertension is substantially worse than for patients with idiopathic PAH.
- Loading...
Loading...
Next post in Pulmonary Vasculature
Loading... 
Loading...